URGN — UroGen Pharma Ltd. price, chart and key statistics

Price data

Price

$33.91

YTD price return

+44.79%

YTD total return

+44.79%

Next earnings

Nov 5, 2026

Market cap

1.7B2018-03 683.3M2026-10 1.7B+142.9% over the window

Enterprise value

1.7B

Shares outstanding

48.9M2016-12 2.3M2026-06 48.9M+2019.9% over the window

52W low

$16.50

52W high

$50.81

From 52W high

-33.26%

From 52W low

+105.52%

52W range

51%

Volume

Rel volume

1.09×

30D volume

946.7K

30D $ vol

36.5M

Fundamentals

Sales (ttm)

188.7M2016-12 17.5M2026-06 188.7M+976.6% over the window

Sales/share

$3.862016-12 $7.602026-06 $3.86-49.2% over the window

EPS (ttm)

-$2.00

FCF (ttm)

-159.1M2016-12 3.5M2026-06 -159.1M-4654.5% over the window

FCF/share

-$3.262016-12 $1.522026-06 -$3.26-314.8% over the window

Book value/share

-$2.712016-12 $7.072026-06 -$2.71-138.3% over the window

Net margin

-51.73%2016-12 -11.1%2026-06 -51.7%+367.2% over the window

ROA

-38.65%2016-12 -8.4%2026-06 -38.7%+359.1% over the window

Current ratio

3.802016-12 7.032026-06 3.80-45.9% over the window

Growth (CAGR, ttm) · 10Y

Sales

+100.37%2025-06-30 → 2026-06-3094.2M → 188.7M (+100.3% total)+37.54%2023-06-30 → 2026-06-3072.5M → 188.7M (+160.3% total)+42.66%2021-06-30 → 2026-06-3031.9M → 188.7M (+490.8% total)+28.44%2016-12-31 → 2026-06-3017.5M → 188.7M (+976.6% total)

Shares

+5.66%2025-06-30 → 2026-06-3046.3M → 48.9M (+5.7% total)+17.30%2023-06-30 → 2026-06-3030.3M → 48.9M (+61.4% total)+16.93%2021-06-30 → 2026-06-3022.4M → 48.9M (+118.6% total)+37.94%2016-12-31 → 2026-06-302.3M → 48.9M (+2019.9% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+89.64%2025-06-30 → 2026-06-30$2.04 → $3.86 (+89.6% total)+17.26%2023-06-30 → 2026-06-30$2.39 → $3.86 (+61.2% total)+22.01%2021-06-30 → 2026-06-30$1.43 → $3.86 (+170.3% total)-6.89%2016-12-31 → 2026-06-30$7.60 → $3.86 (-49.2% total)

Price

+62.69%2025-10-27 → 2026-10-27$20.85 → $33.91 (+62.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+45.26%2023-10-27 → 2026-10-27$11.06 → $33.91 (+206.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.82%2021-10-27 → 2026-10-27$16.27 → $33.91 (+108.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.80%2017-05-04 → 2026-10-27$13.98 → $33.91 (+142.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+62.69%2025-10-27 → 2026-10-27$20.85 → $33.91 (+62.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+45.26%2023-10-27 → 2026-10-27$11.06 → $33.91 (+206.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.82%2021-10-27 → 2026-10-27$16.27 → $33.91 (+108.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.80%2017-05-04 → 2026-10-27$13.98 → $33.91 (+142.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-17.0×2018-03 -34.172026-10 -17.00-50.3% over the window

Fwd P/E

13.2×

P/S (ttm)Market cap ÷ TTM revenue.

8.8×2018-03 83.762026-10 8.79-89.5% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-12.5×2018-03 9.972026-10 -12.53-225.7% over the window

EV/Sales (ttm)

9.2×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-9.60%2017-12 -1.4%2026-06 -8.8%+514.4% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 48.9M ÷ 46.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-5.66%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-5.66%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($633.8M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-5.66%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-39.8M) ÷ today's market cap ($1.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-2.40%2017-12 -8.9%2026-06 -2.2%-75.1% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-39.8M + TTM dividends $0) ÷ today's market cap ($1.7B). Same caveat as the cash buyback yield.

-2.40%2017-12 -8.9%2026-06 -2.2%-75.1% over the window

Vs own 10Y history

P/S

54th

P/B

82nd